Industry: Pharmaceuticals, Biotechnology
Capital Genomix is a privately held biotechnology company located in Gaithersburg, Maryland. The Company was founded in August, 2000 to develop, commercialize and exploit proprietary technologies (GeneSystem320 and ImmunoMouse) and to develop new immunotherapeutic drugs and biomarkers. The team at Capital Genomix is dedicated to its Mission to build shareholder value by utilizing genomic and proteomic technologies to develop novel gene and antibody – based drugs and diagnostics. In order to accomplish this goal, Capital Genomix has built a team of exceptional scientists and business professionals to convert the vision of the Company. More about Capital Genomix is available through the links and contact information provided below: Meet the Capital Genomix Management ( www.capitalgenomix.com )
Capital Genomix , Inc.
9290 Gaither Road
Gaithersburg, Maryland 20877
USA
Tel: (301) 977-3224
Fax: (301) 948-0169